C12 -Malignant neoplasm of pyriform sinus
Specify the patient
Sex Age Region Period Clinical stage TNMAnalysis settings
Analysis settings Change diagnosisExport options
Applied filters (reset filters)
Sex: |
Age: |
Region: |
Period:
C12 – N =764
Year | Stage 1 | Stage 2 | Stage 3 | Stage 4 | Not recorded | Total sum |
1982 | 0% | 7.7% | 46.2% | 46.2% | 0% | 13 |
1983 | 13% | 13% | 26.1% | 39.1% | 8.7% | 23 |
1984 | 0% | 26.7% | 20% | 53.3% | 0% | 15 |
1985 | 12.5% | 12.5% | 4.2% | 70.8% | 0% | 24 |
1986 | 4.3% | 0% | 34.8% | 52.2% | 8.7% | 23 |
1987 | 7.4% | 3.7% | 33.3% | 55.6% | 0% | 27 |
1988 | 14.3% | 14.3% | 7.1% | 60.7% | 3.6% | 28 |
1989 | 3.3% | 6.7% | 36.7% | 43.3% | 10% | 30 |
1990 | 4% | 4% | 12% | 76% | 4% | 25 |
1991 | 3.7% | 14.8% | 18.5% | 48.1% | 14.8% | 27 |
1992 | 0% | 7.7% | 38.5% | 46.2% | 7.7% | 26 |
1993 | 9.5% | 0% | 28.6% | 57.1% | 4.8% | 21 |
1994 | 11.1% | 22.2% | 22.2% | 33.3% | 11.1% | 9 |
1995 | 11.1% | 0% | 22.2% | 44.4% | 22.2% | 9 |
1996 | 0% | 0% | 0% | 100% | 0% | 6 |
1997 | 0% | 0% | 43.8% | 50% | 6.3% | 16 |
1998 | 11.8% | 5.9% | 17.6% | 52.9% | 11.8% | 17 |
1999 | 0% | 8.3% | 25% | 50% | 16.7% | 12 |
2000 | 17.4% | 4.3% | 17.4% | 56.5% | 4.3% | 23 |
2001 | 0% | 3.1% | 34.4% | 53.1% | 9.4% | 32 |
2002 | 4.2% | 4.2% | 25% | 41.7% | 25% | 24 |
2003 | 0% | 0% | 16% | 68% | 16% | 25 |
2004 | 0% | 0% | 27.3% | 63.6% | 9.1% | 22 |
2005 | 2.9% | 2.9% | 25.7% | 60% | 8.6% | 35 |
2006 | 3.8% | 11.5% | 7.7% | 61.5% | 15.4% | 26 |
2007 | 0% | 25% | 20% | 55% | 0% | 20 |
2008 | 3.8% | 7.7% | 26.9% | 57.7% | 3.8% | 26 |
2009 | 3.3% | 6.7% | 6.7% | 76.7% | 6.7% | 30 |
2010 | 6.5% | 3.2% | 16.1% | 67.7% | 6.5% | 31 |
2011 | 2.9% | 5.9% | 8.8% | 82.4% | 0% | 34 |
2012 | 2.9% | 5.7% | 11.4% | 77.1% | 2.9% | 35 |
2013 | 9.1% | 9.1% | 13.6% | 63.6% | 4.5% | 22 |
2014 | 0% | 10.7% | 21.4% | 67.9% | 0% | 28 |